Back to Journals » Degenerative Neurological and Neuromuscular Disease » Therapeutic options in chronic neurodegeneration: from experimental research to clinical practice
Degenerative Neurological and Neuromuscular Disease
ISSN: 1179-9900
- View all (127)
- Volume 14, 2024 (3)
- Volume 13, 2023 (10)
- Volume 12, 2022 (11)
- Volume 11, 2021 (6)
- Volume 10, 2020 (4)
- Volume 9, 2019 (11)
- Volume 8, 2018 (8)
- Volume 7, 2017 (10)
- Volume 6, 2016 (11)
- Volume 5, 2015 (12)
- Volume 4, 2014 (13)
- Volume 3, 2013 (8)
- Volume 2, 2012 (14)
- Volume 1, 2011 (6)
Journal Articles:
- Therapeutic options in chronic neurodegeneration: from experimental research to clinical practice (5)
Therapeutic options in chronic neurodegeneration: from experimental research to clinical practice
Why are the causes of neurodegeneration and neuroinflammation so complex? How can the scientific and medical community proceed in treating them? From the early development phases, clinical trials, regulatory approval and real-world practice, developers have introduced therapeutic options for some neurodegenerative diseases. While chronic neurodegeneration may be heterogenous in nature, the development of treatments can provide reassurance for those affected. This Thematic Series focuses on current treatment modalities and how they are used in clinical practice and to consider emerging therapies being developed for chronic neurodegeneration, alongside further developing an understanding of how these diseases affect individual abilities and functions. Discussion of these issues can help researchers improve the lives of those enduring neurodegenerative diseases, such as Parkinson’s disease, and those that are rarer, including Creutzfeldt-Jakob disease.
Ultrasound-Guided Percutaneous Neuromodulation in Multiple Sclerosis: A Case Report
Javier-Ormazábal A, Herrero P, González-Platas M
Degenerative Neurological and Neuromuscular Disease 2023, 13:15-20
Published Date: 27 January 2023
Neuroimaging Correlates of Patient-Reported Outcomes in Multiple Sclerosis
Jakimovski D, Wicks TR, Bergsland N, Dwyer MG, Weinstock-Guttman B, Zivadinov R
Degenerative Neurological and Neuromuscular Disease 2023, 13:21-32
Published Date: 1 February 2023
Interventions to Improve Quality of Life in Multiple Sclerosis: New Opportunities and Key Talking Points
Faraclas E
Degenerative Neurological and Neuromuscular Disease 2023, 13:55-68
Published Date: 19 September 2023
Practical Guidance on the Use of Cladribine Tablets in the Management or Relapsing Multiple Sclerosis: Expert Opinion from Qatar
Deleu D, Garcia Canibano B, Elalamy O, Sayed Abdelmoneim M, Boshra A
Degenerative Neurological and Neuromuscular Disease 2023, 13:81-88
Published Date: 13 December 2023
Current Perspectives: Obesity and Neurodegeneration - Links and Risks
Kueck PJ, Morris JK, Stanford JA
Degenerative Neurological and Neuromuscular Disease 2023, 13:111-129
Published Date: 3 January 2024